http://www.medcitynews.com/2009/12/pfizer-regenerative-medicine-aims-at-working-with-athersys-to-make-valuable-therapies-for-patients/?utm_source=rss&utm_medium=rss&utm_campaign=pfizer-regenerative-medicine-aims-at-working-with-athersys-to-make-valuable-therapies-for-patients MedCity News Sat, 11 Feb 2012 15:17:29 +0000 hourly 1 http://wordpress.org/?v=3.2.1 http://www.medcitynews.com/2009/12/pfizer-regenerative-medicine-aims-at-working-with-athersys-to-make-valuable-therapies-for-patients/comment-page-1/#comment-57918 Athersys gets U.S., European patents for investigational stem cell therapy : MedCity News Wed, 10 Feb 2010 21:40:02 +0000 http://www.medcitynews.com/?p=16788#comment-57918 [...] headlines in December for striking a development and marketing agreement with Pfizer Regenerative Medicine for a stem cell therapy to treat patients who suffer from inflammatory bowel [...] [...] headlines in December for striking a development and marketing agreement with Pfizer Regenerative Medicine for a stem cell therapy to treat patients who suffer from inflammatory bowel [...]

]]> http://www.medcitynews.com/2009/12/pfizer-regenerative-medicine-aims-at-working-with-athersys-to-make-valuable-therapies-for-patients/comment-page-1/#comment-51869 Biopharmaceutical company Athersys seeks to register 20 million shares, warrants for future sale : MedCity News Thu, 14 Jan 2010 23:49:25 +0000 http://www.medcitynews.com/?p=16788#comment-51869 [...] December, Athersys announced a development and marketing agreement with Pfizer Regenerative Medicine for a stem cell therapy to treat patients who suffer from inflammatory bowel disease. The agreement [...] [...] December, Athersys announced a development and marketing agreement with Pfizer Regenerative Medicine for a stem cell therapy to treat patients who suffer from inflammatory bowel disease. The agreement [...]

]]> http://www.medcitynews.com/2009/12/pfizer-regenerative-medicine-aims-at-working-with-athersys-to-make-valuable-therapies-for-patients/comment-page-1/#comment-46170 Cleveland biopharmaceutical company Athersys teams with Pfizer unit to develop therapy — MedCity Weekend Rounds, Dec. 26, 2009 : MedCity News Sat, 26 Dec 2009 18:45:38 +0000 http://www.medcitynews.com/?p=16788#comment-46170 [...]      ♦   Athersys is a good fit for Pfizer Regenerative Medicine, both culturally and scientifically, said Ruth McKernan, chief scientific officer for the Pfizer unit. Pfizer was looking to partner with an adult stem cell company — rather than buy one — because it’s not sure yet which technology will win in the marketplace. [...] [...]      ♦   Athersys is a good fit for Pfizer Regenerative Medicine, both culturally and scientifically, said Ruth McKernan, chief scientific officer for the Pfizer unit. Pfizer was looking to partner with an adult stem cell company — rather than buy one — because it’s not sure yet which technology will win in the marketplace. [...]

]]>